Blood Pressure Measurement and Treatment Decisions Masked and White-Coat Hypertension

Kazuomi Kario*, Lutgarde Thijs, Jan A. Staessen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

39 Citations (Web of Science)

Abstract

White-coat and masked hypertension are important hypertension phenotypes. Out-of-office blood pressure measurement is essential for the accurate diagnosis and monitoring of these conditions. This review summarizes literature related to the detection and diagnosis, prevalence, epidemiology, prognosis, and treatment of whitecoat and masked hypertension. Cardiovascular risk in white-coat hypertension appears to be dependent on the presence of coexisting risk factors, whereas patients with masked hypertension are at increased risk of target organ damage and cardiovascular events. There is an unmet need for robust data to support recommendations around the use of antihypertensive treatment for the management of white-coat and masked hypertension.

Original languageEnglish
Pages (from-to)990-1008
Number of pages19
JournalCirculation Research
Volume124
Issue number7
DOIs
Publication statusPublished - 29 Mar 2019

Keywords

  • blood pressure
  • diagnosis
  • masked hypertension
  • risk factors
  • stroke
  • white coat hypertension
  • TARGET ORGAN DAMAGE
  • LONG-TERM RISK
  • ISOLATED NOCTURNAL HYPERTENSION
  • ISOLATED SYSTOLIC HYPERTENSION
  • CORONARY-ARTERY-DISEASE
  • CARDIOVASCULAR RISK
  • GENERAL-POPULATION
  • PROGNOSTIC VALUE
  • CAROTID ATHEROSCLEROSIS
  • SUSTAINED HYPERTENSION

Cite this